Role of CXCR3 in Th1-Mediated Lung Injury
Role of CXCR3 in Th1-Mediated Lung Injury
批准号:
6950504
负责人:
Anne M. Manicone
金额:
$4.23万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2005-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): CXCR3 and its ligands are associated with Th1-related responses including allograft rejection and bronchiolitis obliterans. Reduced allograft rejection in CXCR3 knockout mice (KO) suggests an important and non-redundant role of this chemokine receptor. Activated Th1-cells are the predominant expressers of CXCR3, and more recent studies indicate that there is a small population of CXCR3 (+) myeloid cells. Although the role of these CXCR3 (+) myeloid cells is unknown, chemokine receptors may define and recruit populations of myeloid cells with specific effector or accessory functions. In our murine model of Th1-induced lung, CXCR3 ligands appear to be important inflammatory mediators, and host lymphocytes (the predominant expressers of CXCR3) are not required. This preliminary work suggests a role for CXCR3 (+) myeloid cells in lung injury, and we hypothesize that (1) CXCR3 (+) myeloid cells are required for the inflammatory response to Thl cells and (2) these cells secrete proinflammatory cytokines that are critical to the inflammatory response. The goal of this project is to determine the role of CXCR3 (+) myeloid cells in Thl-mediated lung injury, which will lead to a better understanding of other Th1-associated diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
-
批准号:10741574
-
项目类别:
-
资助金额:$73.65万
-
财政年份:2023
-
负责人:Anne M. Manicone
-
依托单位:
Macrophage Signaling Pathways in Acute Lung Injury and Resolution
-
批准号:10359104
-
项目类别:
-
资助金额:$59.03万
-
财政年份:2019
-
负责人:Anne M. Manicone
-
依托单位:
MMP28 Regulation Of Macrophage Recruitment and Polarization
-
批准号:8632040
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2014
-
负责人:Anne M. Manicone
-
依托单位:
Epilysin in Lung Immunity
-
批准号:7211459
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2006
-
负责人:Anne M. Manicone
-
依托单位:
Epilysin in Lung Immunity
-
批准号:7586168
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2006
-
负责人:Anne M. Manicone
-
依托单位:
Epilysin in Lung Immunity
-
批准号:7085954
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2006
-
负责人:Anne M. Manicone
-
依托单位:
Epilysin in Lung Immunity
-
批准号:7390415
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2006
-
负责人:Anne M. Manicone
-
依托单位:
Epilysin in Lung Immunity
-
批准号:7787069
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2006
-
负责人:Anne M. Manicone
-
依托单位:
国内基金
海外基金
登录
查看更多内容
空间转录组学解析CXCL13/CXCR3轴在消痈乳康方重塑肉芽肿性乳腺炎免疫微环境中的空间异质性机制研究
-
批准号:2026JJ82265
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐众
-
依托单位:
固本消积颗粒通过TIMP-1抑制SDF-1/CXCR3依赖性中性粒细胞募集重塑CRC肝前转移生态位的临床及基础研究
-
批准号:2026JJ30171
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭巍
-
依托单位:
CXCR3⁺ Tfh细胞在抗病毒CD8⁺ T细胞免疫应答中的作用及机制研究
-
批准号:2026JJ81841
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘紫嫣
-
依托单位:
短程放疗通过IFN-β-CXCR3/MHC-II轴协同直肠癌化疗免疫治疗的分子机制研究
-
批准号:JCZRLH202500227
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
CXCR3通路参与调控TSPO-18Da在视神经脊髓炎谱系疾病合并神经性疼痛中的机制研究
-
批准号:2025JJ50684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:周小良
-
依托单位:
CXCL10/CXCR3轴介导TAMs炎性微环境促乳腺癌“痰毒传舍于肺”及中药干预机制研究
-
批准号:2025JJ80951
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:范洪桥
-
依托单位:
TDP-43通过CXCL10/CXCR3重塑星形胶质细胞-突触对话介导偏头痛认知障碍机制研究
-
批准号:2025JJ60697
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:龚俏宇
-
依托单位:
GBA介导CXCL10/CXCR3信号通路在快动眼睡眠障碍的作用与机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陈颖
-
依托单位:
心肌特异性Cxcl10靶向Cxcr3介导单核巨噬细胞调控糖尿病心肌病
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:张梦遥
-
依托单位:
巨噬细胞与血管内皮细胞通过CXCL10/CXCR3互作调控KLF2促进炎症介导的肺血管重塑在慢性血栓栓塞性肺动脉高压中的机制研究
-
批准号:82370062
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:洪城
-
依托单位: